Evommune, Inc. (EVMN) — Strategic Asset Allocation Index
Evommune, Inc. (EVMN) has a Strategic Asset Allocation Index of 32.8% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $67.49 Million) total $67.49 Million, measured against net assets of $205.57 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Evommune, Inc. (EVMN) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Evommune, Inc. Strategic Asset Allocation Index (2025–2025)
This chart shows how Evommune, Inc.'s Strategic Asset Allocation Index has evolved across 1 annual periods from 2025 to 2025. As of December 2025, the index stands at 32.8%, representing strategic assets of $67.49 Million against net assets of $205.57 Million USD. For live market cap and overall valuation, see Evommune, Inc. market capitalisation.
Annual Strategic Asset Allocation Index for Evommune, Inc. (2025–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Evommune, Inc. from 2025 to 2025, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Evommune, Inc. book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 32.8% | $67.49 Million | $- | $67.49 Million | $205.57 Million | — |